MENU
+Compare
AMGN
Stock ticker: NASDAQ
AS OF
Aug 15 closing price
Price
$296.47
Change
+$6.18 (+2.13%)
Capitalization
159.61B

AMGN Amgen Forecast, Technical & Fundamental Analysis

Amgen is a leader in biotechnology-based human therapeutics... Show more

Industry: #Biotechnology
AMGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AMGN with price predictions
Aug 15, 2025

AMGN sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for AMGN moved above the 200-day moving average on July 28, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where AMGN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

AMGN moved above its 50-day moving average on August 15, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AMGN advanced for three days, in of 303 cases, the price rose further within the following month. The odds of a continued upward trend are .

AMGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 225 cases where AMGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 05, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on AMGN as a result. In of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for AMGN turned negative on July 30, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 10-day moving average for AMGN crossed bearishly below the 50-day moving average on August 12, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (21.505) is normal, around the industry mean (9.409). P/E Ratio (24.241) is within average values for comparable stocks, (23.546). Projected Growth (PEG Ratio) (1.001) is also within normal values, averaging (1.848). Dividend Yield (0.031) settles around the average of (0.027) among similar stocks. P/S Ratio (4.593) is also within normal values, averaging (3.361).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. AMGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
AMGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

AMGN is expected to report earnings to fall 15.28% to $5.10 per share on October 29

Amgen AMGN Stock Earnings Reports
Q3'25
Est.
$5.10
Q2'25
Beat
by $0.76
Q1'25
Beat
by $0.61
Q4'24
Beat
by $0.27
Q3'24
Beat
by $0.47
The last earnings report on August 05 showed earnings per share of $6.02, beating the estimate of $5.26. With 2.17M shares outstanding, the current market capitalization sits at 159.61B.
A.I.Advisor
published Dividends

AMGN is expected to pay dividends on September 12, 2025

Amgen AMGN Stock Dividends
A dividend of $2.38 per share will be paid with a record date of September 12, 2025, and an ex-dividend date of August 22, 2025. The last dividend of $2.38 was paid on June 06. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of human therapeutic products based on cellular biology

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Biotechnology
Address
One Amgen Center Drive
Phone
+1 805 447-1000
Employees
26700
Web
https://www.amgen.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SVIX18.580.08
+0.43%
-1x Short VIX Futures ETF
PSCQ28.46-0.01
-0.03%
Pacer Swan SOS Conservative (Oct) ETF
PFF31.40-0.04
-0.13%
iShares Preferred&Income Securities ETF
FLIA20.45-0.03
-0.17%
Franklin International Aggregate Bd ETF
ETHV64.21-2.31
-3.47%
VanEck Ethereum ETF

AMGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AMGN has been loosely correlated with ABBV. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if AMGN jumps, then ABBV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMGN
1D Price
Change %
AMGN100%
+2.13%
ABBV - AMGN
54%
Loosely correlated
+0.98%
GILD - AMGN
49%
Loosely correlated
-0.55%
NVS - AMGN
48%
Loosely correlated
+1.74%
PFE - AMGN
44%
Loosely correlated
+0.12%
MRK - AMGN
43%
Loosely correlated
+1.75%
More